Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keywan Mortezaee

Showing results (71-80 of 142) with videos related to

Pageof 15
Sort By:
Pathology, Research and Practice|June 2, 2023
The impact of PD-L1 as a biomarker of cancer responses to combo anti-PD-1/CTLA-4Sasan Parvini, Jamal Majidpoor, Keywan Mortezaee
Drug Delivery and Translational Research|June 1, 2023
Extracellular vesicle-based drug delivery in cancer immunotherapySajad Najafi, Jamal Majidpoor, Keywan Mortezaee
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 28, 2022
Bypassing anti-PD-(L)1 therapy: Mechanisms and management strategiesKeywan Mortezaee, Jamal Majidpoor, Sajad Najafi, et al.
Journal of Cellular Physiology|December 12, 2018
Transforming growth factor-β signaling: Tumorigenesis and targeting for cancer therapyAmirhossein Ahmadi, Masoud Najafi, Bagher Farhood, et al.
Journal of Cellular Biochemistry|May 12, 2018
Roles of methyltrienolone (R1881) in AKTs and AR expression patterns of cultured granulosa-lutein cellsSaeid Nekoonam, Mohammad Naji, Keywan Mortezaee, et al.
Journal of Biochemical and Molecular Toxicology|August 31, 2021
The current knowledge concerning solid cancer and therapyMasoud Najafi, Jamal Majidpoor, Heidar Toolee, et al.
Journal of Cellular Physiology|November 19, 2017
Inflammasome: Its role in traumatic brain and spinal cord injuryKeywan Mortezaee, Neda Khanlarkhani, Cordian Beyer, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 28, 2022
Cancer stem cells in immunoregulation and bypassing anti-checkpoint therapyElnaz Rouzbahani, Jamal Majidpoor, Sajad Najafi, et al.
Medical Oncology (Northwood, London, England)|April 10, 2025
Secretory exosomes from modified immune cells against cancerAsrin Mafakheri, Fardin Fathi, Jamal Majidpoor, et al.
Journal of Cellular Biochemistry|August 8, 2017
Post-treatment of melatonin with CCl<sub>4</sub> better reduces fibrogenic and oxidative changes in liver than melatonin co-treatmentKeywan Mortezaee, Jamal Majidpoor, Erfan Daneshi, et al.
Pageof 15

Showing results (71-80 of 142) with videos related to

Sort By:
Pageof 15
Pathology, Research and Practice|June 2, 2023
The impact of PD-L1 as a biomarker of cancer responses to combo anti-PD-1/CTLA-4Sasan Parvini, Jamal Majidpoor, Keywan Mortezaee
Drug Delivery and Translational Research|June 1, 2023
Extracellular vesicle-based drug delivery in cancer immunotherapySajad Najafi, Jamal Majidpoor, Keywan Mortezaee
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 28, 2022
Bypassing anti-PD-(L)1 therapy: Mechanisms and management strategiesKeywan Mortezaee, Jamal Majidpoor, Sajad Najafi, et al.
Journal of Cellular Physiology|December 12, 2018
Transforming growth factor-β signaling: Tumorigenesis and targeting for cancer therapyAmirhossein Ahmadi, Masoud Najafi, Bagher Farhood, et al.
Journal of Cellular Biochemistry|May 12, 2018
Roles of methyltrienolone (R1881) in AKTs and AR expression patterns of cultured granulosa-lutein cellsSaeid Nekoonam, Mohammad Naji, Keywan Mortezaee, et al.
Journal of Biochemical and Molecular Toxicology|August 31, 2021
The current knowledge concerning solid cancer and therapyMasoud Najafi, Jamal Majidpoor, Heidar Toolee, et al.
Journal of Cellular Physiology|November 19, 2017
Inflammasome: Its role in traumatic brain and spinal cord injuryKeywan Mortezaee, Neda Khanlarkhani, Cordian Beyer, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 28, 2022
Cancer stem cells in immunoregulation and bypassing anti-checkpoint therapyElnaz Rouzbahani, Jamal Majidpoor, Sajad Najafi, et al.
Medical Oncology (Northwood, London, England)|April 10, 2025
Secretory exosomes from modified immune cells against cancerAsrin Mafakheri, Fardin Fathi, Jamal Majidpoor, et al.
Journal of Cellular Biochemistry|August 8, 2017
Post-treatment of melatonin with CCl<sub>4</sub> better reduces fibrogenic and oxidative changes in liver than melatonin co-treatmentKeywan Mortezaee, Jamal Majidpoor, Erfan Daneshi, et al.
Pageof 15